Dr Uyttendaele
ActiveSummary
Dr Uyttendaele has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €586,296 and a net result of €113,817. Equity is growing by ~10.2% per year across the filed fiscal years. The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
11-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2024
27-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
30-06
Financial
Liquidity quadruplescurrent ratio 23.82
Current ratio from 6.46 to 23.82; short-term debt falls from €89,031 to €26,270.
30-06
Financial
Equity above €500,000Eq €608,979 ▲24.2%
6 profitable years in a row build equity to €608,979.
2023
27-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
28-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
17-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2020
22-12
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
30-06
Financial
Highest result since 2019net €135,986 ▲1,489%
Operating result €200,929, net result €135,986, both a record.
2019
18-12
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2018
26-12
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2017
22-12
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
26-01
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.